Aptamer-target interaction descriptor
Aptamer-target interaction information
Interaction ID: 207
Aptamer sequence: GGAAGGCTTTAGGTCTGAGATCTCGG
Target unique ID: P04585
Aptamer ID Aptamer descriptor Target chemistry Target name Affinity Binding Conditions/Buffer PubMed ID
Apta_203 PF1-26ntG Protein POL_HV1H2 233 nM 50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes 22554064
Structure information of aptamer
Aptamer Sequence: GGAAGGCTTTAGGTCTGAGATCTCGG
The optimal secondary structure in dot-bracket notation: ...(((((...)))))..........
The centroid secondary structure in dot-bracket notation: ...(((((...)))))..........
The MFE structure
The Centroid structure
The mountain plot representation
Aptamer information
Type Detail Type Detail
Aptamer ID Apta_203 Description PF1-26ntG
Aptamer chemistry DNA Length 26 nt
GC content 53.8% Molecular weight 8,322.15 Da
Molarity of 1 μg/μl solution 120.16 μM Number of G-quadruplexes No QGRS found
G-Score N/A Function Targeted therapy
Sequence GGAAGGCTTTAGGTCTGAGATCTCGG
Applications Inhibiting function against the WT HIV-1 RT
Target information
Type Detail Type Detail
Uniprot ID P04585 Protein name Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Gene name(s) gag-pol Organism Gag-Pol polyprotein (Pr160Gag-Pol) [Cleaved into: Matrix protein p17 (MA); Capsid protein p24 (CA); Spacer peptide 1 (SP1) (p2); Nucleocapsid protein p7 (NC); Transframe peptide (TF); p6-pol (p6*); Protease (EC 3.4.23.16) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.13) (Exoribonuclease H) (EC 3.1.13.2) (p66 RT); p51 RT; p15; Integrase (IN) (EC 2.7.7.-) (EC 3.1.-.-)]
Status reviewed in uniprot database Length 1435
Mass 162,042 Activity regulation The viral protease is inhibited by many synthetic protease inhibitors (PIs), such as amprenavir, atazanavir, indinavir, loprinavir, nelfinavir, ritonavir and saquinavir
Involvement in disease N/A Catalytic activity Reaction=Specific for a P1 residue that is hydrophobic, and P1' variable
PDB ID(s)
1A30;1BV7;1BV9;1BVE;1BVG;1BWA;1BWB;1C0T;1C0U;1C1B;1C1C;1DMP;1DTQ;1DTT;1E6J;1EP4;1ESK;1EX4;1EXQ;1FB7;1FK9;1FKO;1FKP;1G6L;1HIV;1HVH;1HVR;1HWR;1HXB;1JKH;1JLA;1JLB;1JLC;1JLE;1JLF;1JLG;1JLQ;1KLM;1LV1;1LW0;1LW2;1LWC;1LWE;1LWF;1NCP;1O1W;1ODW;1ODY;1QBR;1QBS;1QBT;1QBU;1REV;1RT1;1RT2;1RT3;1RT4;1RT5;1RT6;1RT7;1RTD;1RTH;1RTI;1RTJ;1S1T;1S1U;1S1V;1S1W;1S1X;1T05;1TAM;1TKT;1TKX;1TKZ;1TL1;1TL3;1VRT;1VRU;2HND;2HNY;2HNZ;2KOD;2NPH;2OPP;2OPQ;2OPR;2OPS;2RF2;2RKI;2WHH;2WOM;2WON;2YNF;2YNG;2YNH;2YNI;3AO2;3C6T;3C6U;3DI6;3DLE;3DLG;3DM2;3DMJ;3DOK;3DOL;3DOX;3DRP;3DRR;3DRS;3DYA;3E01;3FFI;3I0R;3I0S;3KJV;3KK1;3KK2;3KK3;3KT2;3KT5;3LAK;3LAL;3LAM;3LAN;3LP0;3LP1;3LP2;3M8P;3M8Q;3MEC;3MED;3MEE;3MEG;3N3I;3NBP;3PHV;3QIN;3QIO;3QIP;3T19;3T1A;3TAM;4B3O;4B3P;4B3Q;4I7F;4KSE;4KV8;4NCG;4Q1W;4Q1X;4Q1Y;4Q5M;4QLH;4U1H;4U1I;4U1J;4U7Q;4U7V;5DGU;5DGW;5EU7;5HRN;5HRP;5HRR;5HRS;5IM7;5J2M;5J2N;5J2P;5J2Q;5K14;5KAO;5T82;5TC2;5VZ6;5XOS;5XOT;5YRS;6BJ2;6BJ3;6BSG;6BSH;6BSI;6BSJ;6DIF;6DIL;6DJ1;6DJ2;6DJ5;6DJ7;6DV0;6DV4;6E7J;6E9A;6EWA;6EX9;6GL1;6J1V;6J1W;6OR7;6OTZ;6P1I;6P1X;6P2G;6PYL;6SKK;6SKM;6SKN;6SLQ;6SLU;6SMU;6UIR;6UIS;6UIT;6UJX;6UJY;6UJZ;6UK0;6VPZ;6VQ2;6VQD;6VQE;6VQY;6VQZ;6WAZ;6WB1;6WPF;6WPH;6WPJ;
Function Mediates, with Gag polyprotein, the essential events in virion assembly, including binding the plasma membrane.
Activity data

No relevant experimental diagram

Interaction ID 207
Target type Protein
Target unique ID P04585
Activity 233 nM
Binding Conditions/Buffer

50 mM Tris-HCl, pH 8, 1mM DTT, 80 mM KCl, 6 mM MgCl2 for ten minutes

Assay

N/A

PubMed ID 22554064
Similar aptamers
Aptamer ID Aptamer chemistry Sequence Similarity
Apta_196 DNA AGGAAGGCTTTAGGTCTGAGATCTC
88.46%
Apta_184 DNA AGGAAGGCTTTAGGTCTGAGATCTCGGAAT
86.67%
Apta_204 DNA CCAAGGCTTTAGGTCTGAGATCTCCC
84.62%
Apta_205 DNA TTAAGGCTTTAGGTCTGAGATCTCTT
84.62%
Apta_193 DNA AGGAAGGCTTTAGGGTCTGAGATCTCGGAAT
83.87%
Apta_186 DNA AGGAACGCTTTAGGTCTGAGATCTCGGAAT
83.33%
Apta_192 DNA AGGAAGGCTTTAGCTCTGAGATCTCGGAAT
83.33%
Apta_215 DNA AGGAAGGCTTTAGGTCCGAGATCTCGGAAT
83.33%
Apta_202 DNA AAGGCTTTAGGTCTGAGATCTCGGAAT
81.48%
Apta_194 DNA AGGAAGGCTTTAGGGTCTGAGATCTCGGGAAT
81.25%
Apta_195 DNA AGGAAGGCTTTAGGGGTCTGAGATCTCGGAAT
81.25%
Apta_190 DNA AGGAACCCTTTAGGTCTGAGATCTCGGAAT 80.00%
Apta_191 DNA AGGAAGGCTTTACCTCTGAGATCTCGGAAT 80.00%
Apta_185 DNA ACCAAGGCTTTAGGTCTGAGATCTCCCAAT 73.33%
Apta_189 DNA AGGAACCCTTTACCTCTGAGATCTCGGAAT 73.33%
Apta_197 DNA GGCTTTAGGTCTGAGATCTCGGAAT 73.08%
Apta_198 DNA AGGAAGGCTTTAGGTCTGAG 69.23%
Apta_206 DNA AGGAAGGGGTCTGAGATCTCGGAAT 65.38%
Apta_207 DNA AGGAAGGCTTTAGGTGGAAT 65.38%
Apta_212 RNA AGGAAGGCUUUAGGUCUGAGAUCUCGGAAU 63.33%